Condition: Treatment Resistant Depression · Sponsor: LivaNova
Objectives of this study are to determine whether active VNS Therapy treatment is superior to a no stimulation control in producing a reduction in baseline depressive symptom severity, based on multiple depression scale assessment tools at 12 months from randomization.
This description comes directly from the study's public registry record.
Laura Yates, BSN · 281-228-7200 · laura.yates@livanova.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| UAB Huntsville Regional Medical Center | Huntsville, Alabama, United States | Recruiting |
| Access Multi Specialty Medical Clinic, Inc | Burlingame, California, United States | Terminated |
| CMB Clinical Trials | Colton, California, United States | Withdrawn |
| ATP Clinical Research, Inc. | Costa Mesa, California, United States | Recruiting |
| Kaizen Brain Center | La Jolla, California, United States | Recruiting |
| Keck Hospital of USC | Los Angeles, California, United States | Recruiting |
| University of California San Diego | San Diego, California, United States | Active Not Recruiting |
| SF-CARE, Inc. | San Rafael, California, United States | Terminated |
| Syrentis Clinical Research | Santa Ana, California, United States | Withdrawn |
| Sunrise Research Institute | Boca Raton, Florida, United States | Terminated |
| Mindful Behavioral Health | Boca Raton, Florida, United States | Recruiting |
+ 89 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03887715